#533: What’s the Tea on Kratom?
About this episode
This episode discusses the care of patients using kratom and mitragynine-derived substances, including identification and management of use disorders.
Caring for patients using mitragynine-derived substances Familiarize yourself with the differences in mitragynine-derived compounds. Understand how to identify and manage kratom use disorder and withdrawal from mitragynine-derived compounds. We’re joined by Dr. Jonathan Tanawan ( Profile ). Claim CME for this episode at curbsiders.vcuhealth.org ! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME! Credits Written and Produced, with Show Notes, Infographic, and Cover Art by Zina Huxley-Reicher, MD Hosts: Carolyn Chan, MD. MHS and Zina Huxley-Reicher, MD Reviewer: Kento Sonoda, MD, MPH Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Jonathan Tanawan, MD Show Segments Intro, disclaimer, guest bio Guest one-liner, Picks of the Week* Case from Kashlak; Definitions Pharmacology of kratom and other mitragynine-based compounds How to take a mitragynine-specific substance use history Defining a use disorder Withdrawal from kratom Managing a use disorder with MOUD Legal landscape and…
Sponsors
Freed, Figs, Continuing Education Company
More episodes of The Curbsiders Internal Medicine Podcast
- #532: Updates in Fibromyalgia Management featuring Dr. Dan Clauw
- #531 2025 ACLS Guideline Updates Live from #SHM #Converge2026
- REBOOT: #507 Swinging the Pendulum on Menopause Care With Dr Rachel Rubin
- #530 Nutrition with Dr. Joan Salge Blake
- #529 A Case of Syncope with the Clinical Problem Solvers
Explore listener stats, chart rankings, contacts and more on the The Curbsiders Internal Medicine Podcast podcast page.